Asep Medical Holdings Inc (SEPSF)
USD 0.39
(0.0%)
USD 0.39
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.22 Million CAD | -81.82% |
| 2022 | -4.52 Million CAD | -105.67% |
| 2021 | -2.2 Million CAD | -7730.32% |
| 2020 | -28.09 Thousand CAD | -7859.49% |
| 2019 | -353.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -762.02 Thousand CAD | 62.23% |
| 2024 Q2 | -1.12 Million CAD | -47.28% |
| 2023 FY | -8.22 Million CAD | -81.82% |
| 2023 Q3 | -1.31 Million CAD | 47.0% |
| 2023 Q2 | -2.48 Million CAD | -27.81% |
| 2023 Q1 | -1.94 Million CAD | -59.41% |
| 2023 Q4 | -2.01 Million CAD | -53.37% |
| 2022 Q2 | -1.15 Million CAD | 17.75% |
| 2022 Q1 | -1.4 Million CAD | -41.91% |
| 2022 FY | -4.52 Million CAD | -105.67% |
| 2022 Q4 | -1.21 Million CAD | -62.03% |
| 2022 Q3 | -751.86 Thousand CAD | 34.79% |
| 2021 Q2 | -108.4 Thousand CAD | -17.75% |
| 2021 FY | -2.2 Million CAD | -7730.32% |
| 2021 Q1 | -92.05 Thousand CAD | 0.0% |
| 2021 Q4 | -987.8 Thousand CAD | -112.41% |
| 2021 Q3 | -465.05 Thousand CAD | -329.01% |
| 2020 FY | -28.09 Thousand CAD | -7859.49% |
| 2019 FY | -353.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 115.529% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -17.822% |
| CSL Limited | 2.64 Billion USD | 100.311% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 112.632% |
| Regen BioPharma, Inc. | 1.02 Million USD | 903.836% |
| BioStem Technologies, Inc. | -8.48 Million USD | 3.014% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -115.431% |
| Qrons Inc. | -789.34 Thousand USD | -942.295% |
| Nascent Biotech, Inc. | -2.08 Million USD | -294.089% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 86.857% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -4.103% |
| Skye Bioscience, Inc. | -37.64 Million USD | 78.145% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1880.203% |
| Rebus Holdings, Inc. | -1.02 Million USD | -706.601% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 48.163% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -516.08% |
| Genscript Biotech Corporation | -95.47 Million USD | 91.383% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1200.955% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 89.025% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -25.109% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -2909.242% |
| SQZ Biotechnologies Company | -79.46 Million USD | 89.646% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -184.447% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -351.92% |
| Mesoblast Limited | -87.95 Million USD | 90.646% |
| Marizyme, Inc. | -65.34 Million USD | 87.41% |
| Genus plc | 7.9 Million USD | 204.143% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 24.463% |
| Pharming Group N.V. | -10.54 Million USD | 22.001% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -279.172% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -121.747% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 6.973% |
| ContraFect Corporation | -65.15 Million USD | 87.372% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -68.384% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -376.269% |
| IMV Inc. | -36.48 Million USD | 77.451% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -2.08% |
| MultiCell Technologies, Inc. | -380.07 USD | -2164587.558% |
| ONE Bio Corp. | 8.67 Million USD | 194.822% |
| Accustem Sciences Inc. | -3.74 Million USD | -119.605% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 84.084% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -549.286% |
| Q BioMed Inc. | -2.05 Million USD | -300.924% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -120.395% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -245.56% |
| Biomind Labs Inc. | -1.21 Million USD | -577.526% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 86.225% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -165.246% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -322.077% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -54836.752% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -41.43% |
| GB Sciences, Inc. | -1.36 Million USD | -504.206% |
| Alpha Cognition Inc. | -13.77 Million USD | 40.263% |
| HST Global, Inc. | -146.21 Thousand USD | -5527.062% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -368.855% |
| Halberd Corporation | -79.67 Thousand USD | -10225.98% |
| Enzolytics Inc. | -2.17 Million USD | -277.95% |
| Agentix Corp. | -1.37 Million USD | -498.695% |
| Resverlogix Corp. | -3.61 Million USD | -127.904% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -159.42% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 97.212% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 8495.233% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 218.813% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -107.081% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -171.876% |
| AVAX Technologies, Inc. | -6.41 Million USD | -28.278% |
| Zenith Capital Corp. | -10.59 Million USD | 22.354% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -35298.537% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -98.443% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -13512.252% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -310.317% |
| Kadimastem Ltd | -3.3 Million USD | -148.755% |
| Helix BioMedix, Inc. | -1.05 Million USD | -679.061% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -1764.048% |
| LadRx Corporation | 400.44 Thousand USD | 2154.557% |
| Cell Source, Inc. | -5.32 Million USD | -54.614% |
| Regen BioPharma, Inc. | 1.02 Million USD | 903.836% |
| NovAccess Global Inc. | -4.76 Million USD | -72.51% |
| Affymax, Inc. | -14.42 Million USD | 42.961% |
| Itoco Inc. | -1.86 Million USD | -340.201% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -85.194% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -392.95% |
| Mobile Lads Corp. | -2.26 Million USD | -263.512% |
| CytoDyn Inc. | -49.84 Million USD | 83.493% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -10309.991% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -3506.468% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -773.826% |
| SYBLEU INC | -180.3 Thousand USD | -4463.031% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -410.147% |
| International Stem Cell Corporation | -131 Thousand USD | -6180.403% |
| Bioxytran, Inc. | -4.28 Million USD | -92.227% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -15059.434% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -225.159% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 82.885% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -289.183% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -953.588% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -159.701% |
| Neutra Corp. | -233.46 Thousand USD | -3424.009% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 59.453% |
| PureTech Health plc | -65.69 Million USD | 87.477% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 61.313% |
| IXICO plc | -1.17 Million USD | -598.415% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 17.122% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 85.598% |
| CSL Limited | 2.64 Billion USD | 100.311% |
| Cellectis S.A. | -103.17 Million USD | 92.026% |